Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Mutations in the methyl-CpG-binding protein 2 (MECP2) gene are linked to Rett Syndrome (RTT).
• The precise molecular mechanisms underlying RTT neuropathology remain largely unknown.
• Understanding gene expression alterations is crucial for elucidating RTT pathogenesis.

Purpose of the Study:

• To investigate comprehensive gene expression profiles in postmortem brain tissue from RTT patients and controls.
• To identify molecular differences associated with RTT neuropathogenesis.
• To explore the potential of gene expression profiling for classifying human diseases.

Main Methods:

• Utilized multiple cDNA microarray technologies and subtractive hybridization.
• Performed conventional biochemistry for gene expression analysis.
• Applied multiple clustering algorithms to gene expression data.

Main Results:

• Identified increased expression of glial transcripts and decreased expression of neuron-specific mRNAs in RTT brains.
• Observed significant reductions in transcripts encoding presynaptic markers, indicating impaired presynaptic development.
• Successfully segregated RTT from control brain tissue samples based on gene expression profiles using clustering algorithms.

Conclusions:

• Gene expression profiling provides a molecular signature for Rett Syndrome.
• These findings offer insights into the neuropathological mechanisms of RTT.
• This study demonstrates the first successful classification of a complex human disease using gene expression profiling in brain tissue.